Literature DB >> 25225471

An overview of the identification and management of the metabolic syndrome in chiropractic practice.

David R Seaman1, Adam D Palombo2.   

Abstract

OBJECTIVE: This article presents an overview of metabolic syndrome (MetS), which is a collection of risk factors that can lead to diabetes, stroke, and heart disease. The purposes of this article are to describe the current literature on the etiology and pathophysiology of insulin resistance as it relates to MetS and to suggest strategies for dietary and supplemental management in chiropractic practice.
METHODS: The literature was searched in PubMed, Google Scholar, and the Web site of the American Heart Association, from the earliest date possible to May 2014. Review articles were identified that outlined pathophysiology of MetS and type 2 diabetes mellitus (T2DM) and relationships among diet, supplements, and glycemic regulation, MetS, T2DM, and musculoskeletal pain.
RESULTS: Metabolic syndrome has been linked to increased risk of developing T2DM and cardiovascular disease and increased risk of stroke and myocardial infarction. Insulin resistance is linked to musculoskeletal complaints both through chronic inflammation and the effects of advanced glycosylation end products. Although diabetes and cardiovascular disease are the most well-known diseases that can result from MetS, an emerging body of evidence demonstrates that common musculoskeletal pain syndromes can be caused by MetS.
CONCLUSIONS: This article provides an overview of lifestyle management of MetS that can be undertaken by doctors of chiropractic by means of dietary modification and nutritional support to promote blood sugar regulation.

Entities:  

Keywords:  Hyperglycemia; Inflammation; Insulin resistance; Metabolic syndrome X; Weight loss

Year:  2014        PMID: 25225471      PMCID: PMC4161714          DOI: 10.1016/j.jcm.2014.07.002

Source DB:  PubMed          Journal:  J Chiropr Med        ISSN: 1556-3707


  110 in total

Review 1.  Obesity, weight loss and conditional cardiovascular risk factors.

Authors:  T Tzotzas; P Evangelou; D N Kiortsis
Journal:  Obes Rev       Date:  2010-11-03       Impact factor: 9.213

Review 2.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 3.  Omega-3 fatty acids in inflammation and autoimmune diseases.

Authors:  Artemis P Simopoulos
Journal:  J Am Coll Nutr       Date:  2002-12       Impact factor: 3.169

Review 4.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

Authors:  Bharat B Aggarwal
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage.

Authors:  Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

Review 6.  Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training.

Authors:  Barbara J Nicklas; Tongjian You; Marco Pahor
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

7.  Chromium and insulin resistance.

Authors:  Richard A Anderson
Journal:  Nutr Res Rev       Date:  2003-12       Impact factor: 7.800

8.  Lumbar stenosis and systemic diseases: is there any relevance?

Authors:  Raphael Lotan; Amir Oron; Yoram Anekstein; Ehud Shalmon; Yigal Mirovsky
Journal:  J Spinal Disord Tech       Date:  2008-06

Review 9.  Gymnema sylvestre for diabetes mellitus: a systematic review.

Authors:  Matthew J Leach
Journal:  J Altern Complement Med       Date:  2007-11       Impact factor: 2.579

Review 10.  Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.

Authors:  X Palomer; J M González-Clemente; F Blanco-Vaca; D Mauricio
Journal:  Diabetes Obes Metab       Date:  2008-03       Impact factor: 6.577

View more
  2 in total

1.  Effects of interleukin-37 on cardiac function after myocardial infarction in mice.

Authors:  Daoying Xu; Aiqin Wang; Fengqin Jiang; Junhong Hu; Xiuzhou Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Acute Effects of Whole-Body Vibration on the Pain Level, Flexibility, and Cardiovascular Responses in Individuals With Metabolic Syndrome.

Authors:  D C Sá-Caputo; L L Paineiras-Domingos; Ricardo Oliveira; Mario F T Neves; Andrea Brandão; Pedro J Marin; Borja Sañudo; Trentham Furness; Redha Taiar; M Bernardo-Filho
Journal:  Dose Response       Date:  2018-10-07       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.